CoChat
Sign Up
Cited by 61

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

HPV16 E6 augments Wnt signaling in an E6AP-dependent manner

Lichtig, Hava, Gilboa, Daniella Avital, Jackman, Anna, Gonen, Pinhas, Levav-Cohen, Yaara, Haupt, Ygal, Sherman, Levana·2010·Virology
DOI 10.1016/j.virol.2009.10.011
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.virol.2009.10.011

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 60

  1. Alfandari, 1999, HPV16 E6 oncoprotein inhibits apoptosis induced during serum-calcium differentiation of foreskin human keratinocytes, Virology, 257, 383, 10.1006/viro.1999.9675 · DOI · Paper page
  2. Bachar-Dahan, 2006, Engrailed-1 negatively regulates β-catenin transcriptional activity by destabilizing β-catenin via a glycogen synthase kinase-3β-independent pathway, Mol. Biol. Cell, 17, 2572, 10.1091/mbc.e06-01-0052 · DOI
  3. Beaudenon, 2008, HPV E6, E6AP and cervical cancer, BMC Biochem, 9, S4, 10.1186/1471-2091-9-S1-S4 · DOI
  4. Carreras, 2007, A study of Ki-67, c-erbB2 and cyclin D-1 expression in CIN-I, CIN-III and squamous cell carcinoma of the cervix, Histol. Histopathol., 22, 587
  5. Clevers, 2006, Wnt/β-catenin signaling in development and disease, Cell, 127, 469, 10.1016/j.cell.2006.10.018 · DOI · Paper page
  6. Dignam, 1983, Accurate transcription by RNA polymerase II in a soluble extract from isolated mammalian nuclei, Proc. Natl. Acad. Sci. U. S. A., 11, 1475
  7. Gan, 2004, Interaction between JCV large T-antigen and β-catenin, Oncogene, 23, 483, 10.1038/sj.onc.1207018 · DOI
  8. Gazit, 1999, Human frizzed 1 interacts with transforming Wnts to transduce a TCF dependent transcriptional response, Oncogene, 18, 5959, 10.1038/sj.onc.1202985 · DOI
  9. Giles, 2003, Caught up in a Wnt Storm: Wnt signaling in cancer, Biochim. Biophys. Acta, 1653, 1
  10. Golan, 2004, The human frizzled 6 (HFz6) acts as a negative regulator of the canonical Wnt–β-catenin signaling cascade, J. Biol. Chem., 279, 14879, 10.1074/jbc.M306421200 · DOI
  11. Hart, 1999, The F-box protein TrCP associates with phosphorylated beta-catenin and regulates its activity in the cell, Curr. Biol., 9, 207, 10.1016/S0960-9822(99)80091-8 · DOI
  12. Hayward, 2006, Notch and Wnt signaling: mimicry and manipulation by gamma hepesviruses, Sci. STKE, re4
  13. Hendriksen, 2005, RanBP3 enhances nuclear export of active β-catenin independently of CRM1, J. Cell Biol., 171, 785, 10.1083/jcb.200502141 · DOI
  14. Howie, 2009, Papillomavirus E6 proteins, Virology, 384, 324, 10.1016/j.virol.2008.11.017 · DOI
  15. Imura, 2001, Beta-catenin expression as a prognostic indicator in cervical adenocarcinoma, Int. J. Mol. Med., 8, 353
  16. Ishidate, 2000, The APC-hDLG complex negatively regulates cell cycle progression from the G0/G1 to S phase, Oncogene, 19, 365, 10.1038/sj.onc.1203309 · DOI
  17. James, 2006, HPV16-E6 associated hTERT promoter acetylation is E6AP dependent, increased in later passage cells and enhanced by loss of p300, Int. J. Cancer, 119, 1878, 10.1002/ijc.22064 · DOI · Paper page
  18. Kelley, 2005, The global transcriptional effects of the human papillomavirus E6 protein in cervical carcinoma cell lines are mediated by the E6AP ubiquitin ligase, J. Virol., 79, 3737, 10.1128/JVI.79.6.3737-3747.2005 · DOI
  19. Kikuchi, 2003, Tumor formation by genetic mutations in the components of the Wnt signaling pathway, Cancer Sci., 94, 225, 10.1111/j.1349-7006.2003.tb01424.x · DOI
  20. Korinek, 1997, Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma, Science, 275, 1784, 10.1126/science.275.5307.1784 · DOI · Paper page
  21. Levrero, 2006, Viral hepatitis and liver cancer: the case of hepatitis C, Oncogene, 25, 3834, 10.1038/sj.onc.1209562 · DOI
  22. Li, 2007, CBP/p300 are bimodal regulators of Wnt signaling, EMBO J., 26, 2284, 10.1038/sj.emboj.7601667 · DOI
  23. Lichig, 2006, HPV16 E6 natural variants exhibit different activities in functional assays relevant to the carcinogenic potential of E6, Virology, 350, 216, 10.1016/j.virol.2006.01.038 · DOI
  24. Liu, 1999, Multiple functions of human papillomavirus type 16 E6 contribute to the immortalization of mammary epithelial cells, J. Virol., 73, 7297, 10.1128/JVI.73.9.7297-7307.1999 · DOI · Paper page
  25. Liu, 2001, Siah-1 mediates a novel β-catenin degradation pathway linking p53 to adenometous polyposis coli protein, Mol. Cell, 7, 927, 10.1016/S1097-2765(01)00241-6 · DOI
  26. Liu, 2005, The E6AP ubiquitin ligase is required for transactivation of the hTERT promoter by the human papillomavirus E6 oncoprotein, J. Biol. Chem., 280, 10807, 10.1074/jbc.M410343200 · DOI · Paper page
  27. Louria-Hayon, 2009, E6AP promotes the degradation of the PML tumour suppressor, Cell Death Differ., 16, 1156, 10.1038/cdd.2009.31 · DOI
  28. Lustig, 2003, The Wnt signaling pathway and its role in tumor development, J. Cancer Res. Clin. Oncol., 129, 199, 10.1007/s00432-003-0431-0 · DOI
  29. Mammas, 2008, Human papilloma virus (HPV) and host cellular interactions, Pathol. Oncol. Res., 10, 9056
  30. Massimi, 2006, Phosphorylation of the discs large tumour suppressor protein controls its membrane localization and enhances its susceptibility to HPV E6-indued degradation, Oncogene, 25, 4276, 10.1038/sj.onc.1209457 · DOI
  31. Matsumine, 1996, Binding of APC to the human homolog of the Drosophila discs large tumor suppressor protein, Science, 272, 1020, 10.1126/science.272.5264.1020 · DOI
  32. Matthews, 2003, Depletion of Langerhans cells in human papillomavirus type 16-infected skin is associated with E6-mediated down regulation of E-cadherin, J. Virol., 77, 8378, 10.1128/JVI.77.15.8378-8385.2003 · DOI · Paper page
  33. Matsuzawa, 2001, Siah-1, SIP and Ebi collaborate in a novel pathway for beta-catenin degradation linked to p53 responses, Mol. Cell, 7, 915, 10.1016/S1097-2765(01)00242-8 · DOI
  34. McLaughlin-Drubin, 2009, The human papillomavirus E7 oncoprotein, Virology, 384, 335, 10.1016/j.virol.2008.10.006 · DOI
  35. Morin, 1997, Activation of beta-catenin-Tcf sigaling in colon cancer by mutations in beta-catenin or APC, Science, 275, 1787, 10.1126/science.275.5307.1787 · DOI
  36. Mosimann, 2009, β-Catenin hits chromatin: regulation of Wnt target gene activation, Nat. Rev. Mol. Cell Biol., 10, 276, 10.1038/nrm2654 · DOI
  37. Munemitsu, 1995, Regulation of intracellular beta-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein, Proc. Natl. Acad. Sci. U. S. A., 92, 3046, 10.1073/pnas.92.7.3046 · DOI
  38. Nastasi, 2004, Ozz-E3, a muscle-specific ubiquitin ligase, regulates beta-catenin degradation during myogenesis, Dev. Cell, 6, 269, 10.1016/S1534-5807(04)00020-6 · DOI
  39. Pereira-Suarez, 2002, Frequent alterations of the β-catenin protein in cancer of the uterine cervix, Tumour Biol., 23, 45, 10.1159/000048688 · DOI
  40. Perez-Pereira, 2007, Genome wide expression analysis in HPV cervical cancer: identification of altered metabolic pathways, Infect. Agent Cancer, 2, 16, 10.1186/1750-9378-2-16 · DOI
  41. Polakis, 2000, Wnt signaling and cancer, Genes Dev., 14, 1837, 10.1101/gad.14.15.1837 · DOI · Paper page
  42. Rodriguez-Sastre, 2005, Abnormal distribution of E-cadherin and β-catenin in different histologic types of cancer of the uterine cervix, Gyneocol. Oncol., 97, 330, 10.1016/j.ygyno.2004.12.062 · DOI
  43. Rosin-Arbesfeld, 2003, Nuclear export of the APC tumour suppressor controls b-catenin function in transcription, EMBO J., 22, 1101, 10.1093/emboj/cdg105 · DOI
  44. Sadot, 2001, Down regulation of beta-catenin by activated p53, Mol. Cell. Biol., 21, 6768, 10.1128/MCB.21.20.6768-6781.2001 · DOI
  45. Sekaric, 2008, Binding of human papillomavirus Type 16 E6 to E6AP is not required for activation of hTERT, J. Virol., 82, 71, 10.1128/JVI.01776-07 · DOI
  46. Sharma, 2004, PPARγ activation can regulate β-catenin levels via a proteasome mediated and APC independent pathway, J. Biol. Chem., 279, 35583, 10.1074/jbc.M403143200 · DOI
  47. Sherman, 1996, Serum- and calcium-induced differentiation of human keratinocytes is inhibited by HPV16 E6 oncoprotein, J. Virol., 70, 3269, 10.1128/jvi.70.5.3269-3279.1996 · DOI
  48. Sherman, 2002, Inhibition of serum- and calcium-induced terminal differentiation of human keratinocytes by HPV 16 E6: study of the association with p53 degradation, inhibition of p53 transactivation, and binding to E6BP, Virology, 292, 309, 10.1006/viro.2001.1263 · DOI
  49. Shim, 1998, Profiling of differentially expressed genes in human primary cervical cancer by complementary DNA expression array, Clin. Cancer Res., 4, 3045
  50. Shinohara, 2001, Cytoplasmic/nuclear expression without mutation of exon 3 of the β-catenin gene is frequent in the development of the neoplasm of the uterine cervix, Gynecol. Oncol., 72, 450, 10.1006/gyno.2001.6298 · DOI
  51. Shtutman, 1999, The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway, Proc. Natl. Acad. Sci. U. S. A., 96, 5522, 10.1073/pnas.96.10.5522 · DOI · Paper page
  52. Su, 2003, Mutation analysis of CTNNB1 (beta-catenin) and AXIN1, the components of Wnt pathway, in cervical carcinomas, Oncol. Rep., 10, 1195
  53. Takizawa, 2006, Human scribble, a novel tumor suppressor identified as a target of high-risk HPV E6 for ubiquitin-mediated degradation, interacts with adenomatous polyposis coli, Genes Cells, 11, 453, 10.1111/j.1365-2443.2006.00954.x · DOI
  54. Ueda, 2001, Mutations of the beta- and gamma-catenin genes are uncommon in human lung, breast, kidney, cervical and ovarian carcinomas, Br. J. Cancer, 85, 64, 10.1054/bjoc.2001.1863 · DOI
  55. Uren, 2005, Activation of the Canonical Wnt pathway during genital keratinocyte transformation: a model for cervical cancer progression, Cancer Res., 65, 6199, 10.1158/0008-5472.CAN-05-0455 · DOI
  56. Willert, 2006, Wnt signaling: is the party in the nucleus?, Genes Dev., 20, 1394, 10.1101/gad.1424006 · DOI
  57. Xiao, 2003, Adenomatous polyposis coli (APC)-independent regulation of beta-catenin degradation via a retinoid×receptor-mediated pathway, J. Biol. Chem., 278, 29954, 10.1074/jbc.M304761200 · DOI
  58. Xu, 2008, NFX1 interacts with mSin3A/histone deacetylase to repress hTERT transcription in keratinocytes, Mol. Cell. Biol., 28, 4819, 10.1128/MCB.01969-07 · DOI · Paper page
  59. Zur-Hausen, 1996, Papillomavirus infection — a major cause of human cancers, Biochim. Biophys. Acta, 1288, F55
  60. Zur-Hausen, 2002, Papillomaviruses and cancer from basic studies to clinical applications, Nat. Rev. Cancer, 2, 342, 10.1038/nrc798 · DOI

Cited by

See all 61

Metadata

Authors
Lichtig, H., Gilboa, D. A., Jackman, A., Gonen, P., Levav-Cohen, Y., Haupt, Y., & Sherman, L.
Venue
Virology
Publisher
Elsevier BV
Published
2010-01
Volume
396
Issue
1
Pages
47-58
ISSN
0042-6822
DOI
10.1016/j.virol.2009.10.011
Cited by
61
References
3
Language
en
Licence
Funders
Leo Minz Fund for Cancer Research, Tel-Aviv University and the Cooperation Program in Cancer Research of the Deutsches Krebsforschungszentrum (DKFZ) and Israel's Ministry of Sciences and Technology (MOST) (1841)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: HPV16 E6 augments Wnt signaling in an E6AP-dependent manner. https://app.cochat.ai/papers/10.1016/j.virol.2009.10.011
The paper
Lichtig, H., Gilboa, D. A., Jackman, A., Gonen, P., Levav-Cohen, Y., Haupt, Y., & Sherman, L. (2010). HPV16 E6 augments Wnt signaling in an E6AP-dependent manner. Virology. https://doi.org/10.1016/j.virol.2009.10.011